During the last three months, 6 analysts shared their evaluations of Zimmer Biomet Holdings (NYSE:ZBH), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 1 | 4 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $139.17, along with a high estimate of $155.00 and a low estimate of $130.00. Observing a 1.96% increase, the current average has risen from the previous average price target of $136.50.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive Zimmer Biomet...